IRBM S.p.A.

Advaxia Biologics Logo

Next,

Reimagined.

Advancing the next transformative
biotherapeutics.

Microscopic 3-D view of adenovirus behind two lab technicians discussing vialed vaccine in laboratory

Next,

Reimagined.

Advancing the next transformative
biotherapeutics.

cGMP CONTRACT DEVELOPMENT &
MANUFACTURING ORGANIZATION

cGMP CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION

Uniquely equipped CDMO partner with an unparalleled track record.

Fully integrated service portfolio for adenovirus vaccines — from development, to manufacturing of pre-clinical and clinical supply.

WE SPECIALIZE IN:

Expression Systems

We possess extensive experience in generating high quality/GMP enabling materials such as cell lines and virus seed stocks.

Process Development

We blaze new trails in biologics development & manufacturing, by translating leading-edge research data into hands-on, reproducible production know-how that will maximize your probability of success in the clinic.

Analytical Development

Our laboratory possesses industry-leading equipment, software and scientists who specialize in method development, phase appropriate qualification and validation.

cGMP Manufacturing

We have perfected a wide array of adenoviral production platforms, in alignment with the latest industry best practices and regulatory guidelines.

Quality Control

Our dedicated QC team relentlessly seeks out opportunities to improve our capabilities, equipment, staff training and operational standards.

Quality Assurance

We have developed detailed protocols and practices to improve and streamline the QA process across all our project workflows.

Regulatory Support

We provide CMC support throughout every stage of the clinical regulatory process, from drafting to clinical filing, to help maximize the probability of success for approval.

ABOUT US​​

Advaxia is trusted by transformative pharmaceutical and biotech companies throughout the world. We have developed and manufactured Ebola Virus Vaccine for GlaxoSmithKline, served as a testing site for AstraZeneca’s COVID-19 vaccine, manufactured COVID-19 vaccine clinical batches, and we continue to break new ground in the creation of adenovirus-based vaccines. ​

100% Successful
Track Record

At our state-of-the-art facility on the IRBM campus outside Rome, we have set an unparalleled track record in clinical lot success: 100 percent of the batches we manufacture have been approved and released.

Two professional scientists collaborate using industry-leading equipment in Advaxia laboratory

CAREERS

We’re always on the lookout for top performers and leading innovators in the areas of vaccine research, development and biologics manufacturing.

If you think you’ve got what it takes to join our team of path breaking scientists as we embark on further growth, take the next steps here:

NEWS &
EVENTS

14 October 2022

Advaxia’s QP and Scientific Director, Dr. Stefania Di Marco to present at the World Vaccine Congress in Barcelona. Title of Dr. Di Marco’s talk: Viral Vaccine Manufacture:

Viral Vector Vaccines: Adenovirus vaccine production

CONTACT US

Advaxia SRL
Via Pontina km 30,600
00071 Pomezia (RM), Italy
Ph.: +39 06 91093692
Fax: +39 06 91093654

We would love to hear from you.